References
- Gulliford MC, Charlton J. Is relative mortality of type 2 diabetes mellitus decreasing? Am J Epidemiol 2009;169:455-61
- International Diabetes Federation. Available at: http://www.diabetesatlas.org/content/diabetes [Last accessed 10 February 2012]
- Kumar KPS, Bhowmik D, Srivastava S, et al. Diabetes epidemic in India – a comprehensive review of clinical features, management and remedies. The Pharma Innovation 2012;1:17-33
- Newman B, Selby JV, King MC, et al. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987;30:763-8
- Mathias RA, Deepa M, Deepa R, et al. Heritability of quantitative traits associated with type 2 diabetes mellitus in large multiplex families from South India. Metabolism 2009;58:1439-45
- Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005;365:1333-46
- Kunej T, Globocnik Petrovic M, Dovc P, et al. A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians. Folia Biol (Praha) 2004;50:157-8
- Inoguchi T, Sonta T, Tsubouchi H, et al. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 2003;14:S227-32
- Opara EC. Role of oxidative stress in the etiology of type 2 diabetes and the effect of antioxidant supplementation on glycemic control. J Investig Med 2004;52:19-23
- Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84
- Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005;7:1040-52
- Crujeiras AB, Díaz-Lagares A, Carreira MC, et al. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radic Res 2013;47:243-56
- Guzik TJ, West NE, Black E, et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000;102:1744-7
- Letonja MS, Nikolajević-Starčević J, Batista DC, et al. Association of the C242T polymorphism in the NADPH oxidase p22 phox gene with carotid atherosclerosis in Slovenian patients with type 2 diabetes. Mol Biol Rep 2012;39:10121-30
- Jin GM, Piao LS, Li L. Relation of NADPH oxidase subunit p22phox gene C242T polymorphism in Korean patients with diabetic nephropathy in Yanbian. Jilin Med J 2011;32:1336-8
- Doi K, Noiri E, Nakao A, et al. Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in end-stage renal disease. J Hum Genet 2005;50:641-7
- Liu LY, Zou DJ, Zhang J. Association between NADPH oxidase subunit p22phox gene polymorphism and diabetic nephropathy patients in Shanghai. Chin J Nephrol 2006;22:84-7
- Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, et al. Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 2003;26:458-63
- Santos KG, Canani LH, Gross JL, et al. Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients. J Nephrol 2005;18:733-8
- Yan ZD. Association of the P22Phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 2 diabetes. Wuhan University (Master Thesis), 2005;1-34
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9
- Wells GA, Shea B, O’Connell D. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute. Available at: www.ohri.ca/programs/clinical_epidemiology/oxford.asp [Last accessed 20 October 2011]
- Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
- Berkey CS, Hoaglin DC, Mosteller F, et al. A random-effects regression model for meta-analysis. Stat Med 1995;14:395-411
- Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer 1959;22:719-48
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clini Trials 1986;7:177-88
- Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34
- Yin YW, Zhang YD, Wang JZ, et al. Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: a meta-analysis of 6977 subjects. Gene 2012;511:12-17
- Wang Y, Liu Y, Du Y, et al. The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis. Curr Med Res Opin 2013;29:633-42
- Li BH, Zhang LL, Zhang BB, et al. Association between NADPH oxidase p22(phox) C242T polymorphism and ischemic cerebrovascular disease: a meta-analysis. PLoS One 2013;8:e56478